Lukas Pekar
Lukas Pekar publishes mostly in Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology, on topics such as Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research and Glycosylation and Glycoproteins Research.
- World rank
- #937,993 of 7,710,434 ranked researchers
- Rank in Germany
- #46,196 of 364,343
- Works
- 39
- Citations
- 604
- Citations per work
- 15.5
What does Lukas Pekar research?
Lukas Pekar's work is mostly in Medicine (45%), Biochemistry, Genetics and Molecular Biology (33%), Immunology and Microbiology (17%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1949.9%
- Health Sciences1744.8%
- Medicine1744.8%
- Everything else12.7%
- Physical Sciences12.6%
- Engineering12.6%
- 1Radiology, Nuclear Medicine and Imaging31% of their works
- 2Molecular Biology27% of their works
- 3Immunology17% of their works
- 4Oncology14% of their works
- 5Biotechnology6% of their works
- 6Biomedical Engineering3% of their works
Research topics
- Monoclonal and Polyclonal Antibodies Research
- CAR-T cell therapy research
- Glycosylation and Glycoproteins Research
- Protein purification and stability
- Immune Cell Function and Interaction
- Transgenic Plants and Applications
- Advanced Biosensing Techniques and Applications
- Viral Infectious Diseases and Gene Expression in Insects
Which keywords describe Lukas Pekar's research?
The keywords of their largest research topics: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Biopharmaceuticals, Recombinant Proteins and CAR T Cells.
- Mammalian Cells
- High-Throughput Analysis
- Plant Molecular Farming
- NK Cell Recognition
- Protein Aggregation
- Cancer
- CAR T Cells
- Biopharmaceuticals
- Antibody Engineering
- Monoclonal Antibodies
- Glycosylation
- Therapeutic Antibodies
- Fc Receptors
- Recombinant Proteins
- Chimeric Antigen Receptor
- Glycans
- Stability
- Natural Killer Cells
- Vaccine Antigens
- Protein Microarrays
- Recombinant Protein
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 21 words, with their numbers
- Glycosylation473 topics
- Monoclonal Antibodies442 topics
- Therapeutic Antibodies442 topics
- Antibody Engineering351 topic
- Fc Receptors351 topic
- Biopharmaceuticals162 topics
- Recombinant Proteins162 topics
- CAR T Cells121 topic
- Chimeric Antigen Receptor121 topic
- Cancer91 topic
- Glycans91 topic
- Protein Aggregation91 topic
- Stability91 topic
- NK Cell Recognition81 topic
- Natural Killer Cells81 topic
- Plant Molecular Farming71 topic
- Vaccine Antigens71 topic
- High-Throughput Analysis51 topic
- Protein Microarrays51 topic
- Mammalian Cells31 topic
- Recombinant Protein31 topic
Where does Lukas Pekar work?
Lukas Pekar's main affiliation in the publication record is Merck KGaA, Darmstadt (Germany), Germany.
How many publications and citations does Lukas Pekar have?
OpenAlex counts 39 works and 604 citations for Lukas Pekar, an h-index of 15, ranking #937,993 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Lukas Pekar. Posts are plain text and can be reported.